CHI’s 11th Annual Immuno-Oncology Summit Boston

Alloplex CEO, Dr. Frank Borriello is a speaker within the emerging cell-based immunotherapies section.

Topic:

• SUPLEXA Platform for Reprogramming Immune Cells for the Treatment of Cancer.

https://www.immuno-oncologysummit.com/T-Cell